News & Events PhenoVista Biosciences Raises Growth Capital from BroadOak Capital PartnersPhenoVista Biosciences Partners with FUJIFILM Cellular Dynamics to Develop New Applications and Services in hiPSC Drug DiscoveryPhenoVista Biosciences and Inventia Life Science Enter Strategic Partnership to Accelerate Preclinical Research with 3D Cell Models.PhenoVista Biosciences and Yokogawa Life Innovations Partner to Provide Biopharma Researchers with Higher-quality Cell-based Assay OptionsPhenoVista Biosciences Receives $250K Phase 1 SBIR Grant for Microglia Models for Phenotypic Screening of Drugs in Alzheimer’s DiseaseIsoPlexis Names PhenoVista Biosciences a Certified Service ProviderPhenoVista Biosciences Announces $1.4M Phase 2 SBIR Grant for Phenotypic Drug Screening in Alzheimer’s DiseaseOlympus and PhenoVista Collaborate to Deliver an Innovative 3D Cell-Based Assay Service for Drug Discovery
